-
Foundations Direct $5M for Neurodegenerative Tests
Two foundations are spending $5 million to develop new diagnostics for frontotemporal degeneration, an inherited neurodegenerative disorder and form of dementia.
-
Trial Shows Safety, Activity of ALS Stem Cell Therapy
A clinical trial shows a treatment for amyotrophic lateral sclerosis, or ALS, derived from bone marrow stem cells is safe and improves a patient’s condition.
-
Low-Carbon Solutions Set to Change the World
More and more scientists and economists are seeking more immediate natural and technological solutions that could help to save us.
-
Medical Knowledge A.I. Company Raises Early $4.8M
A company developing a system with artificial intelligence to analyze medical literature for treatment insights is raising nearly $5 million in its first venture round.
-
Guidelines for Training New Employees
Managing new team members will require a high amount of patience, communication and time.
-
Institute Invests in Elderly Care Start-Up
Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-term care for older individuals.
-
Retail Clinics Offer A.I.-Enabled Eye Diagnostics
A chain of primary care clinics in grocery stores is adding diagnostics using artificial intelligence to detect an eye disorder resulting from type 2 diabetes.
-
First Blood Disorder Crispr Treatments Reported
Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions.
-
Consortium to Advance A.I. in Longevity Research
A group of academic, foundation, and business organizations are collaborating on the use of artificial intelligence in research on extending life spans.
-
Medicare Buy-In Lowers Costs for Some, Raises Others’ Costs
A plan allowing Americans to opt into Medicare at age 50 would lower insurance premiums for those age 50 to 64, but raise premiums for some younger people.